Australia markets close in 4 hours 9 minutes

Alterity Therapeutics Limited (ATHE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.0700+0.0600 (+2.99%)
At close: 04:00PM EDT
1.9800 -0.09 (-4.35%)
After hours: 05:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 17.33M
Enterprise value 7.03M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)737.73
Price/book (mrq)1.17
Enterprise value/revenue -1.18k
Enterprise value/EBITDA 0.75

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-28.87%
S&P500 52-week change 327.04%
52-week high 35.4100
52-week low 31.5500
50-day moving average 31.9906
200-day moving average 32.3115

Share statistics

Avg vol (3-month) 383.69k
Avg vol (10-day) 334.13k
Shares outstanding 58.73M
Implied shares outstanding 64.46M
Float 82.54B
% held by insiders 10.00%
% held by institutions 11.00%
Shares short (30 Apr 2024) 485.89k
Short ratio (30 Apr 2024) 40.49
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.98%
Shares short (prior month 28 Mar 2024) 423.05k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 309 Jan 2023

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-348.40%

Management effectiveness

Return on assets (ttm)-28.94%
Return on equity (ttm)-53.72%

Income statement

Revenue (ttm)3.43M
Revenue per share (ttm)0.60
Quarterly revenue growth (yoy)-20.30%
Gross profit (ttm)N/A
EBITDA -12.83M
Net income avi to common (ttm)-12.28M
Diluted EPS (ttm)-1.8700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.32M
Total cash per share (mrq)0
Total debt (mrq)255.6k
Total debt/equity (mrq)1.45%
Current ratio (mrq)4.89
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-14.61M
Levered free cash flow (ttm)-9.95M